Boston Scientific
Boston Scientific

Boston Scientific

Health Care Equipment & Supplies
WebsiteInvestor RelationsSEC
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

$61.9B

Market Cap • 10/9/2026

1979

(47 years)

Founded

1992

(34 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

S&P500 Participant

Index Composite • 2026

Valuation

P/B

2,5

P/S

2,9

P/EBITDA

11,1

P/OCF

13,7

P/FCF

17,1

P/E

17,3

BVPS

17,2

EPS

2,5

Market Cap

Market Cap

61,9B

EV

74,3B

EV/Revenue

3,5

EV/EBITDA

13,3

EV/EBIT

17,9

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

3%

Total Yield

3%

Payout

0%

Retained Earnings

7,8B

Profitability

Gross Margin

69,9%

EBITDA Margin

26,5%

EBIT Margin

19,8%

Net Margin

17,5%

D&A/EBITDA

16,5%

R&D/Revenue

10,3%

Capex/Revenue

4,3%

Capex/D&A

64%

Capex/OCF

20%

SBC/OCF

7,1%

% PPE

9,1%

% Goodwill

41,2%

ROE

15,3%

ROIC

10,3%

Growth

CAGR Revenue 5Y

13,4%

CAGR Op. Income 5Y

54,2%

CAGR Net Income 5Y

44,5%

CAGR EPS 5Y

46,2%

CAGR OCF 5Y

15,1%

Leverage

N.D./EBITDA

2,2

Debt/Equity

0%

Current Ratio

1,2

Quick Ratio

0,6

Interest Coverage

1143,8%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium